| Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
|---|---|---|---|---|---|---|
| Marks, 2021 |
USA 2010 - 2019 |
Women who received at least one antidepressant prescription 3 months prior to conception through delivery. | Pregnant women with one (or more) prescription of Desvenlafaxine written during the time period studied. (This is a subgroup of exposure among the whole exposed group considered in the study). |
exposed to other treatment, sick
Pregnant women with one (or more) prescription of Bupropion written during the time period studied. |
16 / 406 | '252 women (6.8%) prescribed >1 antidepressant'=> considered as monotherapy. |
| Study | Country Study period |
Case | Control | Sample size | Rmk |
|---|---|---|---|---|---|
| Anderson, 2020 |
USA 1997 - 2011 |
The case infants were infants born alive or died at 20 SG or more and who had received a diagnosis of at least one selected birth defect. | The controls were live-born infants with no major birth defects who were randomly selected from hospital or state birth-certificate records from the same geographic areas. | 30630 / 11478 | 'Infants with recognized or strongly suspected chromosomal abnormalities or single-gene conditions were excluded from the study.' |